Schedule 13D ownership disclosure

KalVista Pharmaceuticals Inc

Security class unavailable · CUSIP: 483497103

Event date: 2019-04-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
786,270
Percent of class
4.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-020958
Form type
SC 13D/A
Filer
KalVista Pharmaceuticals, Inc.
CIK
CIK 1348911
Filed
Apr 24, 2019
Reporting period
Apr 22, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub